GPT and obesity due to melanocortin 4 receptor deficiency: We first analysed whether the different treatments (HFD, DDE or HFD+DDE) differentially affected obesity development (body weight gain and weights of visceral fat pads), and serum levels of metabolites related to lipid metabolism (triglycerides and cholesterol levels) and hepatic injury (ALT and AST).